Jim Simons Sio Gene Therapies Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.28 - $0.44 $13,239 - $20,804	47,284 Added 13.06%	409,284 $178,000
Q3 2022 Nov 14, 2022	SELL	$0.28 - $0.41 $27,550 - $40,341	-98,394 Reduced 21.37%	362,000 $101,000
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $26,689 - $77,934	-106,759 Reduced 18.82%	460,394 $166,000
Q1 2022 May 13, 2022	SELL	$0.55 - $1.47 $47,600 - $127,224	-86,547 Reduced 13.24%	567,153 $380,000
Q4 2021 Feb 11, 2022	SELL	$1.29 - $2.36 $204,984 - $375,011	-158,903 Reduced 19.55%	653,700 $843,000
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $1.47 Million - $2.19 Million	812,603 New	812,603 $1.76 Million
Q2 2021 Aug 13, 2021	SELL	$2.07 - $2.89 $997,133 - $1.39 Million	-481,707 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.34 - $3.44 $1.13 Million - $1.66 Million	481,707 New	481,707 $1.26 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.